Cite
Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure ( CORONA).
MLA
Haver, Vincent G., et al. “Telomere Length and Outcomes in Ischaemic Heart Failure: Data from the COntrolled ROsuvastatin MultiNAtional Trial in Heart Failure ( CORONA).” European Journal of Heart Failure, vol. 17, no. 3, Mar. 2015, pp. 313–19. EBSCOhost, https://doi.org/10.1002/ejhf.237.
APA
Haver, V. G., Mateo Leach, I., Kjekshus, J., Fox, J. C., Wedel, H., Wikstrand, J., de Boer, R. A., van Gilst, W. H., McMurray, J. J. V., van Veldhuisen, D. J., & van der Harst, P. (2015). Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure ( CORONA). European Journal of Heart Failure, 17(3), 313–319. https://doi.org/10.1002/ejhf.237
Chicago
Haver, Vincent G., Irene Mateo Leach, John Kjekshus, Jayne C. Fox, Hans Wedel, John Wikstrand, Rudolf A. de Boer, et al. 2015. “Telomere Length and Outcomes in Ischaemic Heart Failure: Data from the COntrolled ROsuvastatin MultiNAtional Trial in Heart Failure ( CORONA).” European Journal of Heart Failure 17 (3): 313–19. doi:10.1002/ejhf.237.